Roman Gregory Meyliker is a Galloway, New Jersey based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 54 W Jimmie Leeds Rd Ste 6, Galloway. Patients can reach him at 609-748-9600.
Roman Gregory Meyliker deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Roman Gregory Meyliker speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Roman Gregory Meyliker
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DMD
Accepts Medicare Assignment:
May Accept
Practice Address:
54 W Jimmie Leeds Rd Ste 6, Galloway, New Jersey, 08205-9438
Phone:
609-748-9600
Fax:
609-748-9611
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
9436399250
Enrollment ID:
I20151012001259
NPI Number:
1932491479
NPI Enumeration Date:
03 May, 2011
NPI Last Update On:
22 Jun, 2015
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
54 W Jimmie Leeds Rd Ste 6, Galloway, New Jersey
Zip:
08205-9438
Phone Number:
609-748-9600
Fax Number:
609-748-9611
Patients can reach Roman Gregory Meyliker at 54 W Jimmie Leeds Rd Ste 6, Galloway, New Jersey or can call to book an appointment on 609-748-9600. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.